Navigation Links
Paragon CRT (paflufocon B)

ProductsParagon CRT (paflufocon B)
Company Paragon Vision Sciences
Item Paragon CRT (paflufocon B)
Features CRT has been made possible by five new technologies:
  • Advances in multicurve GP lenses specifically designed to facilitate the safe redistribution of corneal tissue while sleeping.
  • Advances in computer controlled lathing technology, allowing complex lens designs to be consistently fabricated and, in the case of Paragon CRT, with seamless, polishless surfaces and on a tolerance level measured in microns.
  • The development of stable, wettable, high Dk materials that can be safely worn overnight.
  • Advances in computerized corneal mapping techniques providing more precise fitting and follow-up patients.
  • A greater understanding of how corneal reshaping works and the tissues involved in the process.
Description These are rigid gas permeable contact lenses used for corneal refractive therapy, a process that temporarily corrects nearsightedness (myopia). The patient wears the lenses overnight while sleeping and removes them upon wakening. During the day, nearsightedness is corrected or greatly reduced

The Paragon CRT and Quadra RG contact lenses apply slight pressure to the center of the cornea, causing it to temporarily flatten. The flattened cornea redirects light onto the back surface of the eye (the retina) at an angle that can compensate for nearsightedness. Since the cornea is elastic, it gradually regains its shape throughout the day (causing nearsightedness to return). Usually, patients must wear the lenses every night to maintain corrected vision.

The lenses are used for the temporary correction of nearsightedness. They can be used by patients with or without vision distortion (astigmatism). They are usually worn overnight as part of a corneal refractive therapy program. When the lenses are removed each morning, they must be cleaned using a chemical disinfection system.

Why Paragon CRT is the right choice for your practice:

  • Paragon CRT brings opportunity for your practice growth and patient retention.
  • Take advantage! Refractive surgery has created a market of patients wanting freedom from glasses and daytime contacts without surgery.
  • Paragon CRT sets the standard for Corneal Refractive Therapy not only with the first FDA approval for overnight CRT but also by offering a Total System which includes a Diagnostic Dispensing System and a Complete Practice Management Program.
  • With no age restrictions, Paragon CRT is the perfect option for active kids and teens who arent eligible for refractive surgery.
  • Paragon CRT rounds out your practice and is the perfect complement for refractive surgery and 30-day continuous wear lenses.
Info Paragon Vision Sciences
Customer Service: (800) 528-8279
Web site: http://www.paragonvision.com

Related medicine products :

1. Paragon CRT 100 (paflufocon D)
2. Paragon Quadra RG (paflufocon B)
3. Paragon Quadra RG 100 (paflufocon D)
4. Paragon CZE 2000 Capillary Electrophoresis System
5. Paragon™ Nitinol Paired Helical Basket
6. Paragonimiasis Antibody
... Rayvisc is designed with optimum molecular weight ... anterior chamber and coats and protects the ... has the right balance of cohesion, adhesion, ... that the modern phaco surgeon expects from ...
... is a sterile, non-pyrogenic, transparent viscoelastic ... high molecular weight (average = 5 ... Healon GV contains 14 mg/mL of ... physiological sodium chloride-phosphate buffer (pH 7.0-7.5). ...
... PROVISC ophthalmic viscosurgical device ... is characterized by high molecular ... surface tension. It provides excellent ... and is easily removed. It ...
... Every once in awhile, a product comes ... everything else in its category. The new ... just such a product. Built on the ... widely used surgical navigation system in the ...
Medicine Products:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Vida ... raised an $18M Series B led by Canvas Ventures . Other investors include ... to scale its mobile platform to serve more consumers who are managing chronic ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... The Compretta ... commercial and residential clients in and around the Hancock County area, is announcing the ... Hancock County Food Pantry. , The Hancock County Food Pantry has worked for more ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in ... MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that meets the needs ... where and when it’s needed. , A 2’ x 4’ model features ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , December 8, 2016 ... on the research, distribution, and marketing of pharmaceutical drug ... by patent protection and expiration. Additionally, these firms typically ... sector as a whole. Up for review this morning ... Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), Pernix ...
(Date:12/8/2016)... , Dec. 8, 2016 Spotlight ... advancing technologies designed to address rare, emerging and ... Chitra Edwin , Ph.D., RAC, as Senior Vice ... will provide leadership for all U.S. and international ... preparation of regulatory submissions, serving as the primary ...
(Date:12/7/2016)... "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by PNS ... in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially available ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... on Lantus expired in 2014. Lantus is the brand name for ...
Breaking Medicine Technology: